1. Prostaglandin E2 receptor EP2 mediates Snail expression in hepatocellular carcinoma cells
   SHAN-YU CHENG et al, 2014 CrossRef
2. The cyclic AMP signaling pathway: Exploring targets for successful drug discovery (Review).
   Kuo Yan et al, 2016, Mol Med Rep CrossRef
3. Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.
   Hai Zhang et al, 2014, Int J Oncol CrossRef
4. Prostaglandin E2 promotes the cell growth and invasive ability of hepatocellular carcinoma cells by upregulating c-Myc expression via EP4 receptor and the PKA signaling pathway
   SHUKAI XIA et al, 2014 CrossRef
5. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor
   MINGZHAN DU et al, 2015 CrossRef
6. The master regulator FUBP1: its emerging role in normal cell function and malignant development
   Lydie Debaize et al, 2018, Cell. Mol. Life Sci. CrossRef
7. Specific autoantigens identified by sera obtained from mice that are immunized with testicular germ cells alone
   Hayato Terayama et al, 2016, Sci Rep CrossRef
8. FBP1 and p27kip1 Expression After Sciatic Nerve Injury: Implications for Schwann Cells Proliferation and Differentiation
   Li Yao et al, 2014, J. Cell. Biochem. CrossRef
9. The Splicing Factor FUBP1 Is Required for the Efficient Splicing of OncogeneMDM2Pre-mRNA
   Aishwarya G. Jacob et al, 2014, J. Biol. Chem. CrossRef
10. Highly specific and sensitive immunoassay for the measurement of prostaglandin E2in biological fluids
    Yuan Gao et al, 2015, Bioanalysis CrossRef
11. Prostaglandin E2inhibits resveratrol-induced apoptosis through activation of survival signaling pathways in HCT-15 cell lines
    Salman Ul Islam et al, 2015, Animal Cells and Systems CrossRef
12. Far Upstream Element Binding Protein Plays a Crucial Role in Embryonic Development, Hematopoiesis, and Stabilizing Myc Expression Levels
    Weixin Zhou et al, 2016, The American Journal of Pathology CrossRef
13. IL-6 Overexpression in ERG-Positive Prostate Cancer Is Mediated by Prostaglandin Receptor EP2
    Constanze Merz et al, 2016, The American Journal of Pathology CrossRef
14. Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression
    Tingting Fang et al, 2016, Cell Biol Toxicol CrossRef
15. Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
    Mara Massimi et al, 2019, Cells CrossRef
16. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma.
    Yang Chen et al, 2020, Int J Biol Markers CrossRef
17. Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients
    Junyan Zhu et al, 2018, Oncotarget CrossRef
18. Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)
    Yao Ye et al, 2020, J Cancer Res Clin Oncol CrossRef
19. EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases
    Alaleh Zati Zehni et al, 2020, IJMS CrossRef
20. Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma (Review)
    Juthamas Yosudjai et al, 2019, biom rep CrossRef
21. Roles of Aminoacyl-tRNA Synthetases in Cancer
    Zheng Zhou et al, 2020, Front. Cell Dev. Biol. CrossRef
22. Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
    Federica Finetti et al, 2020, Biology CrossRef
23. Tuberin Regulates Prostaglandin Receptor–Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells
    Chenggang Li et al, 2017, Mol Cancer Res CrossRef
24. Pathophysiological role of prostaglandin E synthases in liver diseases
    De-Long Xu et al, 2021, Prostaglandins & Other Lipid Mediators CrossRef
25. Inhibition of PKC/MEK Pathway Suppresses β1-integrin and Mitigates Breast Cancer Cells proliferation
    Nahla E. EL-Ashmawy et al, 2021, Toxicology Reports CrossRef
26. Long non-coding RNA KRT8P41/miR-193a-3p/FUBP1 axis modulates the proliferation and invasion of chordoma cells
    Hai Wen et al, 2021, Journal of Bone Oncology CrossRef
27. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview
    Simone Brivio et al, 2018, gene expr CrossRef
28. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma
    Chao Chen et al, 2022, Front. Cell Dev. Biol. CrossRef
29. Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis
    Krishnendu Khan et al, 2022, Translational Oncology CrossRef
30. New 11-Methoxymethylgermacranolides from the Whole Plant of Carpesium divaricatum
    Tao Zhang et al, 2022, Molecules CrossRef
31. The diagnostic utility of miRNA and elucidation of pathological mechanisms in major depressive disorder
    Cyrus Su Hui Ho et al, 2023, Comprehensive Psychiatry CrossRef